Adjuvant chemoradiation with weekly cisplatin did not significantly improve survival outcomes — but did increase toxicities — compared with adjuvant radiotherapy alone in women with early-stage cervical carcinoma who have intermediate risk factors following radical hysterectomy, a phase 3 trial found. The current standard for women with early-stage disease and intermediate-risk factors is radiotherapy alone...
.png)
55W 14th St Ste 101, Helena, MT, 59601 US
+1 (406) 319 1601
news.in.usa@olahost.top
Copyright © 2024 olasport. All Rights Reserved
